U.S. FDA: No Higher Deaths with Bristol-Myers Squibb Company, Elan Corporation PLC Drug
Reuters -- An analysis by U.S. regulators found Bristol-Myers Squibb and Elan Corp's antibiotic Maxipime was not associated with a higher rate of death compared with similar drugs, the Food and Drug Administration said on Wednesday.